Novo Nordisk Finds Medicare Patients Prefer GLP-1 Pill Over Shot for Weight Loss
Novo Nordisk A/S said its market research shows twice as many US Medicare recipients would rather take a…
Novo’s Wegovy Pill Wins Approval in UK for Obesity Treatment
Novo Nordisk A/S’s Wegovy pill was approved in the UK, opening up the obesity market to people who…
Novo Nordisk’s Wegovy Pill Draws 10,000-Person UK Waiting List at Chemist4U
Chemist4U already has a waiting list of more than 10,000 customers interested in Novo Nordisk A/S’s Wegovy pill,…
Novo Nordisk CEO Looks Beyond Weight Loss to Longevity, Aesthetics
Novo Nordisk A/S Chief Executive Officer Mike Doustdar says the company’s blockbuster obesity drugs could ultimately pull it…
Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales
Novo Nordisk A/S saw a 40% surge in sales of its diabetes and weight-loss drugs in India last…
Novo Rebrands Diabetes Pill as Ozempic to Tap Blockbuster Name
Novo Nordisk A/S is rebranding an existing, less-popular diabetes tablet as Ozempic in the US in a bid…
Novo Says Priority Is Obesity Despite Investor Calls to Expand
Novo Nordisk A/S is doubling down on obesity and diabetes, putting it at loggerheads with investors calling for…